Literature DB >> 11750789

Paradoxical trafficking and regulation of 5-HT(2A) receptors by agonists and antagonists.

J A Gray1, B L Roth.   

Abstract

5-Hydroxytryptamine(2A) (serotonin(2A), 5-HT(2A)) receptors are important for many physiologic processes including platelet aggregation, smooth muscle contraction, and the modulation of mood and perception. A large number of pharmaceutical agents mediate their actions, at least in part, by modulating the number and/or activity of 5-HT(2A) receptors. Drugs with action at 5-HT(2A) receptors are used in the treatment of many disorders, including schizophrenia, depression, and anxiety disorders. This review summarizes over two decades of research on the regulation of 5-HT(2A) receptors and provides a comprehensive review of numerous in vivo studies describing the paradoxical phenomenon of 5-HT(2A) receptor down-regulation by chronic treatment with antidepressants and antipsychotics. In addition, studies reporting antagonist-induced internalization of 5-HT(2A) receptors and other G protein-coupled receptors will be highlighted as a possible mechanism to explain this paradoxical down-regulation. Finally, a review of the cellular and molecular mechanisms that may be responsible for agonist-mediated desensitization and internalization of 5-HT(2A) receptors will be presented.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750789     DOI: 10.1016/s0361-9230(01)00623-2

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  90 in total

Review 1.  Serotonin receptor signaling and regulation via β-arrestins.

Authors:  Laura M Bohn; Cullen L Schmid
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-10-07       Impact factor: 8.250

2.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

3.  Agonist- and antagonist-induced sequestration/internalization of neuropeptide Y Y1 receptors in HEK293 cells.

Authors:  Leng Hong Pheng; Yvan Dumont; Alain Fournier; Jean-Guy Chabot; Alain Beaudet; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

4.  Serotonin 5-HT2A receptors in the CA1 field of the hippocampus mediate head movements in the rabbit.

Authors:  Kuldip D Dave; Gayani S Fernando; Jennifer L Quinn; John A Harvey; Vincent J Aloyo
Journal:  Psychopharmacology (Berl)       Date:  2004-04-24       Impact factor: 4.530

Review 5.  Recent advances in drug action and therapeutics: relevance of novel concepts in G-protein-coupled receptor and signal transduction pharmacology.

Authors:  C B Brink; B H Harvey; J Bodenstein; D P Venter; D W Oliver
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

Review 6.  Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery.

Authors:  Terry Kenakin; Laurence J Miller
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

7.  Chronic olanzapine activates the Stat3 signal transduction pathway and alters expression of components of the 5-HT2A receptor signaling system in rat frontal cortex.

Authors:  N A Muma; R K Singh; M S Vercillo; D N D'Souza; B Zemaitaitis; F Garcia; K J Damjanoska; Y Zhang; G Battaglia; L D Van de Kar
Journal:  Neuropharmacology       Date:  2007-07-01       Impact factor: 5.250

Review 8.  Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia.

Authors:  Jiri Horacek; Vera Bubenikova-Valesova; Milan Kopecek; Tomas Palenicek; Colleen Dockery; Pavel Mohr; Cyril Höschl
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

9.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

10.  Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses.

Authors:  Aaron R Best; Wade G Regehr
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.